Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Kasper

Showing results (161-170 of 199) with videos related to

Pageof 20
Sort By:
Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.
Transfusion|November 1, 1985
Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesC M Heldebrant, E D Gomperts, C K Kasper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 1995
Aortic dissection in a cardiac allograft recipient: a case reportP H Pak, A M Gillinov, R H Hruban, et al.
Blood|December 1, 1986
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitorsJ Batlle, M F Lopez Fernandez, M Campos, et al.
European Cells & Materials|December 20, 2011
Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behaviorM Bongio, J J J P van den Beucken, M R Nejadnik, et al.
Thrombosis and Haemostasis|September 1, 1995
Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTHC K Kasper, D L Aronson, G Davignon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 30, 2009
The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipientsMichelle M Kittleson, Diane V Skojec, Ilan S Wittstein, et al.
Circulation|March 9, 2011
Transcriptomic biomarkers for the accurate diagnosis of myocarditisBettina Heidecker, Michelle M Kittleson, Edward K Kasper, et al.
European Heart Journal|December 25, 2009
The gene expression profile of patients with new-onset heart failure reveals important gender-specific differencesBettina Heidecker, Guillaume Lamirault, Edward K Kasper, et al.
Blood|December 1, 1985
Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopeniaM E Eyster, D A Whitehurst, P M Catalano, et al.
Pageof 20

Showing results (161-170 of 199) with videos related to

Sort By:
Pageof 20
Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.
Transfusion|November 1, 1985
Evaluation of two viral inactivation methods for the preparation of safer factor VIII and factor IX concentratesC M Heldebrant, E D Gomperts, C K Kasper, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|September 1, 1995
Aortic dissection in a cardiac allograft recipient: a case reportP H Pak, A M Gillinov, R H Hruban, et al.
Blood|December 1, 1986
The heterogeneity of type IIA von Willebrand's disease: studies with protease inhibitorsJ Batlle, M F Lopez Fernandez, M Campos, et al.
European Cells & Materials|December 20, 2011
Biomimetic modification of synthetic hydrogels by incorporation of adhesive peptides and calcium phosphate nanoparticles: in vitro evaluation of cell behaviorM Bongio, J J J P van den Beucken, M R Nejadnik, et al.
Thrombosis and Haemostasis|September 1, 1995
Comparison of six commercial plasma references for factor VIII, factor IX and von Willebrand factor. On behalf of the Subcommittee for Factor VIII and IX of the Scientific and Standardization Committee of the ISTHC K Kasper, D L Aronson, G Davignon, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 30, 2009
The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipientsMichelle M Kittleson, Diane V Skojec, Ilan S Wittstein, et al.
Circulation|March 9, 2011
Transcriptomic biomarkers for the accurate diagnosis of myocarditisBettina Heidecker, Michelle M Kittleson, Edward K Kasper, et al.
European Heart Journal|December 25, 2009
The gene expression profile of patients with new-onset heart failure reveals important gender-specific differencesBettina Heidecker, Guillaume Lamirault, Edward K Kasper, et al.
Blood|December 1, 1985
Long-term follow-up of hemophiliacs with lymphocytopenia or thrombocytopeniaM E Eyster, D A Whitehurst, P M Catalano, et al.
Pageof 20